While Wegovy uses semaglutide for weight loss, other formulations help treat diabetes and prevent heart attacks, and even help manage serious liver disease
Blood-based bioenergetics: a liquid biopsy of mitochondrial dysfunction in disease
& Long, Y
Brito, of the Mayo Clinic, looked at data from January 1, 2014 to December 31, 2021 on 351,913 patients who started taking either a GLP-1 drug, a sodium-glucose cotransporter 2 inhibitor (SGLT2i) like Jardiance or Farxiga, dipeptidyl peptidase-4 inhibitor (DPP4i) like Januvia and Onglyza, or a sulfonylurea such as Glucotrol
This is the core population where semaglutide's risk-benefit profile is well-characterized and the clinical rationale is straightforward
or if you take other diet pills